Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to ropivacaine for saphenous nerve block in ACL reconstruction
2014-000299-25Phase 2Completed
- Sponsor
- UKH Salzburg
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in postoperative pain comparing Ropivacaine with Ropivacaine + dexmedetomidine (2 arms). Primary endpoint: Duration of sensory block defined by demand for first analgesic. Started Oct 2014; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2014-000299-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000299-25.